GGrantIndex
Sort

64,565 grants matching drug discovery

Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies

$611,276
Sergiy Denysenko · Alchem Laboratories Corporation · N01 · FY2021 · CA

Immunology Team Contributions to the LSB

$611,223
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

NEW APPROACHES TO TARGET SPECIFIC ANTIFUNGAL AGENTS

$611,210
Georgetown University · R01 · FY2001 · CA

Ubiquitin E3 ligase detection by fluorescence resonance transfer

$611,190
David E Sterner · Progenra, Inc. · R44 · FY2015 · GM

HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I

$611,149
Matt Surman · Albany Molecular Research, Inc. · N01 · FY2025 · DA

Microtubule Regulation

$611,119
Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R01 · FY2009 · GM

Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology

$611,076
Charles M. Rice · Rockefeller University · R01 · FY2024 · AI

Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology

$611,076
Charles M. Rice · Rockefeller University · R01 · FY2023 · AI

Central Motivation of Depression; An Expanded Kynurenine Theory

$611,054
Robert H. McCusker · University Of Illinois At Urbana-Champaign · R01 · FY2014 · MH

Arteriogenesis and Arterial Branching

$610,915
Michael Simons · Yale University · R01 · FY2011 · HL

WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE

$610,912
Kooresh Isaac Shoghi · Washington University · U24 · FY2019 · CA

Novel Screening Platform for Discovery of DUB Targeting Probes

$610,908
Sara J Buhrlage · Dana-Farber Cancer Inst · R01 · FY2021 · CA

CAREER: Molecular mechanisms behind the venom phenotype of ectoparasitoid wasps

$610,890
Ellen O Martinson · University Of New Mexico · · FY2025 · BIO

Genetic Variation in Opioid Induced Respiratory Depression in Mice

$610,811
Jason A Bubier · Jackson Laboratory · R01 · FY2024 · DA

A Bioengineering Approach to Develop a Laminar 3D Cerebellar Neuronal Circuit for Modeling Human Cerebellum

$610,752
Kathleen Joyce Millen · Seattle Children'S Hospital · R01 · FY2023 · NS

Toxicology in the 21st Century Program (Tox21) - Systems Toxicology

$610,750
Menghang Xia · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

CETP and HDL Function in Cardiovascular Diseases

$610,711
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2015 · HL

THE DINUCLEOTIDE SB-9000 A NOVEL ANTI-HBV AGENT

$610,629
Radhakrishnan P Iyer · Spring Bank Technologies, Inc. · U01 · FY2007 · AI

Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer

$610,563
Carol Ann Lange · University Of Minnesota · R01 · FY2020 · CA

High Throughput Modular Microfluidic Systems for Drug Discovery/Development

$610,512
Steven A. Soper · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2009 · EB

Target discovery and combination therapy in KRAS mutant cancer

$610,483
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Fox COBRE Phase II Admin Core

$610,481
Joseph M Fox · University Of Delaware · P20 · FY2021 · GM

Project 3: Laboratory: Pharmacotherapies for Opioid Use Disorder

$610,451
Sandra D. Comer · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U54 · FY2015 · DA

The Role in OAT1 in Uremia

$610,415
Sanjay K Nigam · University Of California, San Diego · R01 · FY2025 · DK

The Role in OAT1 in Uremia

$610,305
Sanjay K Nigam · University Of California, San Diego · R01 · FY2023 · DK